MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic EPS (earnings per share) 1986–2027

Medtronic's diluted EPS in Q1 FY2027, the three months to 31 July 2026, was 1.14 USD, up 40.7% on the same quarter a year before. Medtronic's diluted earnings per share over the last twelve months were 4.06 USD, up 11.8% on the twelve months before. In fiscal year 2026 they were 3.73 USD, up 3.3% on the year before.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM31 Jul 20264.06+11.85%4.09
FY202624 Apr 20263.73+3.32%3.75
FY202525 Apr 20253.61+30.80%3.63
FY202426 Apr 20242.76-2.13%2.77
FY202328 Apr 20232.82-24.40%2.83
FY202229 Apr 20223.73+40.23%3.75
FY202130 Apr 20212.66-24.86%2.68
FY202030 Apr 20203.54+3.81%3.57
FY201926 Apr 20193.41+50.22%3.44
FY201827 Apr 20182.27-21.45%2.29
FY201728 Apr 20172.89+16.53%2.92
FY201629 Apr 20162.48+2.90%2.51
FY201530 Apr 20152.41-20.20%2.44
FY201425 Apr 20143.02-10.39%3.06
FY201330 Apr 20133.37-1.17%3.40
FY201230 Apr 20123.41+19.23%3.43
FY201130 Apr 20112.86+2.51%2.87
FY201030 Apr 20102.79+51.63%2.80
FY200930 Apr 20091.84-5.64%1.85
FY200830 Apr 20081.95-19.09%1.97
FY200730 Apr 20072.41+15.31%2.44
FY200630 Apr 20062.09+41.22%2.11
FY200530 Apr 20051.48-7.50%1.49
FY200430 Apr 20041.60+23.08%1.61
FY200330 Apr 20031.30+62.50%1.31
FY200230 Apr 20020.80-5.88%0.81
FY200130 Apr 20010.85-4.49%0.87
FY200030 Apr 20000.89+128.21%0.91
FY199930 Apr 19990.39-23.53%0.40
FY199830 Apr 19980.51+2.00%0.52
FY199730 Apr 19970.50+11.11%0.51
FY199630 Apr 19960.45+40.63%0.45
FY199530 Apr 19950.32+28.00%0.32
FY199430 Apr 19940.25+19.05%0.25
FY199330 Apr 19930.21+23.53%0.21
FY199230 Apr 19920.17+21.43%0.17
FY199130 Apr 19910.14+16.67%0.14
FY199030 Apr 19900.12+9.09%0.12
FY198930 Apr 19890.11+10.00%0.11
FY198830 Apr 19880.10+11.11%0.10
FY198730 Apr 19870.09+50.00%0.09
FY198630 Apr 19860.06—0.06

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Medtronic's EPS

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.